SCHEMBL6168220

SCHEMBL6168220

O=C1Nc2ccc(F)cc2C(c2ccccc2)N1C1CCN(Cc2ccccc2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 3/20 0.49
CHRM3 P20309 3/20 0.49
CYP2D6 P10635 2/20 0.49
CYP2C9 P11712 2/20 0.49
CYP2C19 P33261 2/20 0.49
CYP3A4 P08684 1/20 0.49
DRD2 P14416 2/20 0.48
DRD4 P21917 1/20 0.48
DRD3 P35462 1/20 0.48
OPRL1 P41146 1/20 0.47
TP53 P04637 2/20 0.46
ALDH1A1 P00352 1/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
BCHE P06276 2/20 0.45
ACHE P22303 2/20 0.45
BACE1 P56817 2/20 0.45
SIGMAR1 Q99720 4/20 0.44
HTR2A P28223 1/20 0.44
HTR2C P28335 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8565541 0.89 CHRM2 (0.54) CHRM2CHRM3CYP2D6CYP2C9CYP2C19
SCHEMBL8567873 0.88 MEN1 (0.49) CHRM2CHRM3DRD2DRD4DRD3
SCHEMBL6167277 0.88 CHRM3 (0.53) CHRM2CHRM3CYP2D6CYP2C9CYP2C19
SCHEMBL6168075 0.88 CHRM3 (0.50) CHRM2CHRM3CYP2D6CYP2C9CYP2C19
SCHEMBL6168606 0.87 OPRL1 (0.52) CHRM2CHRM3CYP2D6CYP2C9CYP2C19
SCHEMBL29445321 0.87 OPRL1 (0.52) CHRM2CHRM3CYP2D6CYP2C9CYP2C19
SCHEMBL6166885 0.85 CHRM3 (0.52) CHRM2CHRM3DRD2DRD4DRD3
SCHEMBL6168575 0.82 CHRM3 (0.50) CHRM2CHRM3DRD2DRD4DRD3
SCHEMBL8564439 0.81 CHRM2 (0.55) CHRM2CHRM3CYP2D6CYP2C9CYP2C19
Hydrochloric Acid SCHEMBL6166573 0.81 CHRM3 (0.49) CHRM2CHRM3DRD2DRD4DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1122253-B1 QUINAZOLINONE DERIVATIVES SUMITOMO PHARMA (JP) 2005-08-17 EP disclosed
US-6645971-B1 Pollakiuria and urinary incontinence treatment; muscarinic receptor antagonists; anticholinergic, anticonvulsants, antiulcer, and antiasthmatics; Parkinson*s disease SUMITOMO PHARMACEUTICALS COMPANY LIMITED (JP) 2003-11-11 US disclosed
EP-1122253-A1 QUINAZOLINONE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2001-08-08 EP disclosed